A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

Kennedy repeatedly refused to acknowledge scientific consensus that childhood vaccines don’t cause autism and that COVID-19 ...

(HealthDay News) — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The Executive Council blocked a $25,000 contract until Dartmouth Health proved to state prosecutors that it's complying with the Patient Bill of Rights and not denying treatment based on someone's ...

R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...

Citing unverified data, Robert F. Kennedy Jr. claimed in December 2021 that the Covid-19 vaccine was the “deadliest vaccine ...

Nearly two years into the COVID-19 pandemic, Canada is ramping up its vaccine program in an effort to deliver booster doses to eligible Canadians. A booster shot is an additional dose of a COVID ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...